Portfoliotracker

Flerie AB (publ)

FLERIE.ST · STOCKHOLM · Healthcare Biotechnology 20/100 E

12,85 SEK
▼ −0,15 (−1,15 %)
Trading
Price as of 17. 11. 14:11, fetched 17. 11. 15:36
Next earnings–
Ex-dividend–
Analysts–
50 / 200 day average– / –

Price

Portfoliotracker score20 / 100 Market cap1,18 mld. SEK P/E– Forward P/E-31,7 P/S– P/B0,3 EV/EBITDA– Dividend yield– FCF yield-3,18 % EPS-11,21 SEK Net margin0,0 % Return on equity-27,7 % Beta-0,26 Debt / equity0,00
52-week range 12,30 to 34,21
3-month average volume0,1 M

Finance

Where the revenue goes

Loading the income statement flow…

Fundamentals

Loading key figures…

Insiders, analysts and people

All trades and changes

Loading insiders, analysts and opinions…

Co se právě děje

AI souhrn
Objednat AI souhrn, co se u firmy právě děje Vytvoří se jednou na pozadí a pak ho uvidí všichni. Ve verzi Free 3 objednávky měsíčně.

About the company

Flerie AB (publ) is a venture capital firm specializing in early-stage investments. The firm seeks to invest in life science, biotech and pharma companies engaged in drug development and associated tools or applications tackling major medical challenges of our time. The firm seeks to invest in Europe, Nordic, United States and Israel. Flerie AB (publ) was founded in 2011 and is based in Stockholm, Sweden with additional office in London, United Kingdom.

Website
flerie.com
Employees
8
Country
Sweden
Data since
11. 10. 2016

Explore further

Similar companies HNSA.STEGTX.STBINV.STYUBICO.ST

Intraday chart

Your own portfolio, properties and finances in one place.

The account is free with no time limit. Only you see your data; nobody adds it up with others.

This is saved to your account. You can keep browsing, calculating and comparing without signing in.

Welcome back

Sign in and pick up where you left off.

or continue with

No account yet? Create a free account